{"result": "(\"entity\"<|>DE LORGERIL M<|>PERSON<|>De Lorgeril M is a researcher involved in studies related to cardiovascular health and dietary impacts on heart disease.)\n##\n(\"entity\"<|>RENAUD S<|>PERSON<|>Renaud S is a researcher who has contributed to studies on the Mediterranean diet and its effects on cardiovascular health.)\n##\n(\"entity\"<|>MAMELLE N<|>PERSON<|>Mamelle N is a researcher who has co-authored studies on dietary fatty acids and cardiovascular risk factors.)\n##\n(\"entity\"<|>SALEN P<|>PERSON<|>Salen P is a researcher involved in studies examining the impact of dietary fats on heart disease.)\n##\n(\"entity\"<|>MARTIN JL<|>PERSON<|>Martin JL is a researcher who has contributed to the understanding of dietary influences on cardiovascular health.)\n##\n(\"entity\"<|>MONJAUD I<|>PERSON<|>Monjaud I is a researcher who has worked on studies related to dietary fats and cardiovascular outcomes.)\n##\n(\"entity\"<|>LYON DIET HEART STUDY<|>EVENT<|>The Lyon Diet Heart Study is a significant clinical trial that investigated the effects of the Mediterranean diet on cardiovascular health.)\n##\n(\"entity\"<|>PREDIMED STUDY<|>EVENT<|>The PREvención con DIeta MEDiterránea (PREDIMED) Study is a major research project focused on the Mediterranean diet and its effects on cardiovascular disease.)\n##\n(\"entity\"<|>N Engl J Med<|>ORGANIZATION<|>The New England Journal of Medicine is a prestigious medical journal that publishes research articles on various health topics, including cardiovascular studies.)\n##\n(\"entity\"<|>Lancet<|>ORGANIZATION<|>The Lancet is a leading medical journal that publishes research and reviews on health and medicine, including studies on diet and cardiovascular health.)\n##\n(\"entity\"<|>Am J Clin Nutr<|>ORGANIZATION<|>The American Journal of Clinical Nutrition is a journal that publishes research on nutrition and its effects on health, including cardiovascular outcomes.)\n##\n(\"entity\"<|>Circulation<|>ORGANIZATION<|>Circulation is a journal that focuses on cardiovascular medicine and publishes research related to heart disease and its prevention.)\n##\n(\"entity\"<|>Br J Nutr<|>ORGANIZATION<|>The British Journal of Nutrition is a journal that publishes research on nutrition and its impact on health, including cardiovascular disease.)\n##\n(\"relationship\"<|>DE LORGERIL M<|>LYON DIET HEART STUDY<|>De Lorgeril M was a key researcher in the Lyon Diet Heart Study, which examined the Mediterranean diet's effects on heart disease<|>8)\n##\n(\"relationship\"<|>RENAUD S<|>LYON DIET HEART STUDY<|>Renaud S contributed to the Lyon Diet Heart Study, focusing on dietary impacts on cardiovascular health<|>8)\n##\n(\"relationship\"<|>MAMELLE N<|>LYON DIET HEART STUDY<|>Mamelle N was involved in the Lyon Diet Heart Study, researching dietary fatty acids and cardiovascular risk<|>8)\n##\n(\"relationship\"<|>SALEN P<|>LYON DIET HEART STUDY<|>Salen P participated in the Lyon Diet Heart Study, investigating the Mediterranean diet's role in heart disease prevention<|>8)\n##\n(\"relationship\"<|>MARTIN JL<|>LYON DIET HEART STUDY<|>Martin JL was a researcher in the Lyon Diet Heart Study, contributing to findings on diet and cardiovascular health<|>8)\n##\n(\"relationship\"<|>MONJAUD I<|>LYON DIET HEART STUDY<|>Monjaud I was involved in the Lyon Diet Heart Study, focusing on dietary influences on heart disease<|>8)\n##\n(\"relationship\"<|>MAMELLE N<|>PREDIMED STUDY<|>Mamelle N contributed to the PREDIMED Study, which investigated the Mediterranean diet's effects on cardiovascular disease<|>8)\n##\n(\"relationship\"<|>RENAUD S<|>PREDIMED STUDY<|>Renaud S was involved in the PREDIMED Study, focusing on dietary impacts on cardiovascular health<|>8)\n##\n(\"relationship\"<|>DE LORGERIL M<|>PREDIMED STUDY<|>De Lorgeril M contributed to the PREDIMED Study, examining the Mediterranean diet's role in heart disease prevention<|>8)\n##\n(\"relationship\"<|>MARTIN JL<|>PREDIMED STUDY<|>Martin JL was a researcher in the PREDIMED Study, contributing to findings on diet and cardiovascular health<|>8)\n##\n(\"relationship\"<|>MONJAUD I<|>PREDIMED STUDY<|>Monjaud I was involved in the PREDIMED Study, focusing on dietary influences on cardiovascular outcomes<|>8)\n##\n(\"relationship\"<|>N Engl J Med<|>LYON DIET HEART STUDY<|>The Lyon Diet Heart Study was published in the New England Journal of Medicine, highlighting its significance in cardiovascular research<|>7)\n##\n(\"relationship\"<|>Lancet<|>LYON DIET HEART STUDY<|>The findings of the Lyon Diet Heart Study were discussed in The Lancet, emphasizing its impact on dietary recommendations<|>7)\n##\n(\"relationship\"<|>Am J Clin Nutr<|>PREDIMED STUDY<|>The PREDIMED Study was published in the American Journal of Clinical Nutrition, showcasing its importance in nutrition research<|>7)\n##\n(\"relationship\"<|>Circulation<|>PREDIMED STUDY<|>The PREDIMED Study findings were published in Circulation, underlining its relevance to cardiovascular health<|>7)\n##\n(\"relationship\"<|>Br J Nutr<|>PREDIMED STUDY<|>The PREDIMED Study was featured in the British Journal of Nutrition, highlighting its contributions to understanding diet and heart disease<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 47.  De Lorgeril M, Renaud S, Mamelle N, Salen P, Mar-                             fatty acids in patients with multiple cardiovascular\n     tin JL, Monjaud I, et al. Mediterranean alpha-lino-                           risk factors. N Engl J Med. 2013; 368:1800-8.\n     leic acid-rich diet in secondary prevention of coro-                    60.   Sala-Vila A, Guasch-Ferré M, Hu FB, Sánchez-Tain-\n     nary heart disease. Lancet 1994; 343: 1454-9.                                 ta A, Bulló M, Serra-Mir M, López-Sabater C, et al.\n48.  De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye                          Dietary   α-Linolenic Acid, Marine ω-3 Fatty Acids,\n     J, Mamelle N. Mediterranean diet, traditional risk                            and Mortality in a Population With High Fish Con-\n     factors, and the rate of cardiovascular complications                         sumption: Findings From the PREvención con DIe-\n     after myocardial infarction: final report of the Lyon                         ta MEDiterránea (PREDIMED) Study. J Am Heart\n     Diet Heart Study. Circulation 1999; 99: 779-85.                               Assoc. 2016 Jan 26;5(1). pii: e002543.\n49.  Wang C, Harris WS, Chung M,                  et al.  n-3 Fatty          61.   Kotwal S, Jun M, Sullivan D, et al. Omega 3 Fatty\n     acids from fish or fish-oil supplements, but not al-                          acids and cardiovascular outcomes: systematic re-\n     pha-linolenic acid, benefit cardiovascular disease                            view and meta-analysis. Circ Cardiovasc Qual Out-\n     outcomes in primary- and secondary-prevention                                 comes 2012; 5:808-18.\n     studies: a systematic review. Am J Clin Nutr. 2006;                     62.   Delgado-Lista J, Perez-Martinez P, Lopez-Miranda\n     84:5-17.                                                                      J, et al. Long chain omega-3 fatty acids and car-\n50.  Pan A, Chen M, Chowdhury R, et al.                 α-Linolenic                diovascular disease: a systematic review. Br J Nutr.\n     acid and risk of cardiovascular disease: a systema-                           2012;107: S201-13.\n     tic review and meta-analysis. Am J Clin Nutr. 2012;                     63.   Kwak SM, Myung S-K, Lee YJ, et al. Efficacy of ome-\n     96:1262-73.                                                                   ga-3 fatty acid supplements (eicosapentaenoic acid\n51.  Ortega Anta RM, González Rodríguez LG, Villalo-                               and docosahexaenoic acid) in the secondary pre-\n     bos Cruz T,      et al.  Food sources and adequacy of                         vention of cardiovascular disease: a meta-analysis\n     intake of omega 3 and omega-6 fatty acids in a                                of randomized, double-blind, placebo-controlled\n     representative      sample      of  Spanish      adults.   Nutr               trials. Arch Intern Med. 2012; 172:686-94.\n     Hosp. 2013; 28: 2236-45.                                                64.   Rizos EC, Ntzani EE, Bika E, et al. Association be-\n52.  EFSA. Scientific Opinion on Dietary Reference Va-                             tween omega-3 fatty acid supplementation and\n     lues    for  fats,   including     saturated      fatty   acids,              risk of major cardiovascular disease events: a syste-\n---\n 342      BLOQUE: LÍPIDOS\n\n\n\n      matic     review    and   meta-analysis.       JAMA.     2012;   78.  Kris-Etherton PM, Harris WS, Appel LJ, for the Nu-\n      308:1024-33.                                                          trition Committee. AHA Scientific Statement. Fish\n65.   Wen YT, Dai JH, Gao Q. Effects of Omega-3 fatty                       consumption, fish oil, omega-3 fatty acids, and\n      acid on major cardiovascular events and mortality                     cardiovascular disease. Arterioscler Thromb Vasc\n      in patients with coronary heart disease: a me-                        Biol 2003; 23: e20-e31.\n      ta-analysis of randomized controlled trials. Nutr                79.  González-Estecha M, Bodas-Pinedo A, Guillén-Pé-\n      Metab Cardiovasc Dis. 2014; 24:470-5.                                 rez JJ, Rubio-Herrera MÁ, Martínez-Álvarez JR, He-\n66.   Guallar E, Aro A, Jiménez FJ, Martín-Moreno JM,                       rráiz-Martínez MÁ, et al. Documento de consenso\n      Salminen I, Van’t Veer P,            et al.  Omega-3 fatty            sobre la exposición de metil mercurio en España.\n      acids in adipose tissue and risk of myocardial in-                    Nutr Hosp. 2015; 31:16-31.\n      farction. The EURAMIC study. Arterioscler Thromb                 80.  Guall\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}